4
Changes in Ownership
Aptevo Therapeutics Inc. Filed Acc 0001209191-23-045267
SVP, CFO acquired 6,945 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Taylor Daphne SVP, CFO | 2023-08-08 | Option exercise | +6,945 | 12,368 | D | ||
| Derivatives | |||||||
| Taylor Daphne SVP, CFO | 2023-08-08 | Option exercise · Restricted Stock Unit | −6,945 | 6,944 | D | ||
Loading xslF345X05/doc4.xml…